DK280085A - 7alfa-acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner samt deresfremstilling og anvendelse - Google Patents

7alfa-acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner samt deresfremstilling og anvendelse Download PDF

Info

Publication number
DK280085A
DK280085A DK280085A DK280085A DK280085A DK 280085 A DK280085 A DK 280085A DK 280085 A DK280085 A DK 280085A DK 280085 A DK280085 A DK 280085A DK 280085 A DK280085 A DK 280085A
Authority
DK
Denmark
Prior art keywords
9alfa
11alfa
7alfa
spirox
acylthio
Prior art date
Application number
DK280085A
Other languages
English (en)
Other versions
DK173854B1 (da
DK280085D0 (da
Inventor
Michel Biollaz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK280085D0 publication Critical patent/DK280085D0/da
Publication of DK280085A publication Critical patent/DK280085A/da
Application granted granted Critical
Publication of DK173854B1 publication Critical patent/DK173854B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
DK198502800A 1984-06-21 1985-06-20 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater DK173854B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH300984 1984-06-21
CH464684 1984-09-28
CH464684 1984-09-28

Publications (3)

Publication Number Publication Date
DK280085D0 DK280085D0 (da) 1985-06-20
DK280085A true DK280085A (da) 1985-12-22
DK173854B1 DK173854B1 (da) 2001-12-27

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198502800A DK173854B1 (da) 1984-06-21 1985-06-20 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater

Country Status (16)

Country Link
US (1) US4670551A (da)
EP (1) EP0165902B1 (da)
AR (2) AR242036A1 (da)
AU (1) AU582754B2 (da)
CA (1) CA1239388A (da)
DE (1) DE3569540D1 (da)
DK (1) DK173854B1 (da)
ES (2) ES8704967A1 (da)
FI (1) FI83225C (da)
GR (1) GR851499B (da)
HU (1) HU192232B (da)
IE (1) IE58050B1 (da)
IL (1) IL75569A (da)
NO (1) NO165496C (da)
NZ (1) NZ212492A (da)
PT (1) PT80663B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT973791E (pt) * 1995-12-11 2007-09-26 Searle Llc Processo para a preparação de um composto epoxi
EP1223174A3 (en) * 1996-12-11 2005-03-16 G.D. Searle & Co. Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
DK0944644T3 (da) * 1996-12-11 2003-02-03 Searle & Co Fremgangsmåde til fremstilling af 3-keto-7-alfa-alkoxycarbonyl-delta-4,5-steroider og mellemprodukter, som er nyttite derfor
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
EP1455795A1 (en) 2001-12-12 2004-09-15 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
ATE51233T1 (de) * 1983-08-17 1990-04-15 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Also Published As

Publication number Publication date
EP0165902B1 (de) 1989-04-19
NO165496C (no) 1991-02-20
AR245731A1 (es) 1994-02-28
IE851535L (en) 1985-12-21
FI852430A0 (fi) 1985-06-19
FI83225B (fi) 1991-02-28
AU4397185A (en) 1986-01-02
DE3569540D1 (en) 1989-05-24
NO165496B (no) 1990-11-12
HU192232B (en) 1987-05-28
DK173854B1 (da) 2001-12-27
AR242036A1 (es) 1993-02-26
IL75569A (en) 1989-03-31
EP0165902A2 (de) 1985-12-27
PT80663B (en) 1987-05-08
DK280085D0 (da) 1985-06-20
GR851499B (da) 1985-11-25
ES8707737A1 (es) 1987-08-16
ES557112A0 (es) 1987-08-16
NZ212492A (en) 1989-02-24
FI83225C (fi) 1991-06-10
IE58050B1 (en) 1993-06-16
ES8704967A1 (es) 1987-04-16
AU582754B2 (en) 1989-04-13
CA1239388A (en) 1988-07-19
PT80663A (en) 1985-07-01
NO852501L (no) 1985-12-23
EP0165902A3 (en) 1986-10-22
FI852430L (fi) 1985-12-22
IL75569A0 (en) 1985-10-31
HUT38367A (en) 1986-05-28
ES544387A0 (es) 1987-04-16
US4670551A (en) 1987-06-02

Similar Documents

Publication Publication Date Title
DK129386D0 (da) Iodpropargylethere, deres fremstilling og anvendelse
DK416985A (da) Substitueret 1,4-dihydropyridincarbonyl-piperidinoforbindelser samt deres fremstilling og anvendelse
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
DK420785D0 (da) 13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
DK519586A (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK280085A (da) 7alfa-acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner samt deresfremstilling og anvendelse
NO854968L (no) Alkosymetyleter- og alkoksymetylesterderivater.
DK514382A (da) Azolylvinyldithioacetaler, deres fremstilling og anvendelse
DK380286A (da) Sulfonamider, deres fremstilling og anvendelse
DK295785A (da) 1,8-diacyloxy-10-acyl-anthroner, deres fremstilling og anvendelse
DK289287D0 (da) 1-phenylalkylimidazol-4- og/eller -5-carboxamider samt deres fremstiling og anvendelse
DK393285D0 (da) Substituerede carbonylphenylsulfonylguanidiner samt deres fremstilling og anvendelse
DK396886A (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK119585D0 (da) 1,2,4-triazacycloalkadienderivater samt deres fremstilling og anvendelse
DK451786D0 (da) Transglucosidase, fremstilling og anvendelse deraf
DK162979C (da) Polyfluoralkylestere, deres fremstilling og anvendelse
DK8887A (da) Substituerede 1,3,5-oxadiazin-2-oner samt deres fremstilling og anvendelse
DK538382A (da) P-oxooxazolidinylbenzensulfonamider, deres fremstilling og anvendelse
DK377786A (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
DK516982A (da) P-phenylendiaminer, deres fremstilling og anvendelse
DK181485A (da) 3-substituerede thiopyroner samt deres fremstilling og anvendelse
DK393986D0 (da) Lactamamider, deres fremstilling og anvendelse
DK421485A (da) Substituerede 1,1-bis-azolyl-butan-2-oner og -oler samt deres fremstilling og anvendelse
DK451486D0 (da) Alkenylazoler, deres fremstilling og anvendelse
DK169484D0 (da) Beta-oxo-alfa-carbamoyl-pyrrolpropionitriler samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK